Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Idun Genomics IVS
IVS
Dissolved
CVR 38003429
Rosmosevej 8
Forskning og eksperimentel udvikling indenfor bioteknologi · NACE 721100
Est. 2016
— employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2018
DKK 0
EBITDA margin
—
Equity ratio
100.0%
Financial strength
Net profit 2018
DKK 1K
0% vs 2017
EBITDA — year on year
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2017
0M
0%
2018
Key figures
Annual report 2018
Revenue
DKK 0
—
EBITDA
DKK 0
—
Net profit
DKK 1K
+0%
Total assets
DKK 1K
-21%
Equity
DKK 1K
-21%
Employees
—
—
Company information
Legal name
Idun Genomics IVS
CVR number
38003429
Legal form
Iværksætterselskab
NACE code
721100 · Forskning og eksperimentel udvikling indenfor bioteknologi
Founded
12. september 2016
Share capital
DKK 2
Employees
—
VAT registered
No
Audit selected
No
Last report
2018-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede direktion.
Contact
Address
Rosmosevej 8
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Forskning og eksperimentel udvikling indenfor bioteknologi
Companies in Allerød
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2017
0M
2018
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2017
0M
2018
Income statement
DKK thousands
Item
2017
2018
Revenue
0
0
Staff expenses
-0
-0
EBITDA
-1
0
Depreciation & amort.
-0
-0
EBIT
-1
0
Net financials
3
1
Profit before tax
2
1
Tax
0
-0
Net profit
1
1
Balance sheet
DKK thousands
Item
2017
2018
Total assets
2
1
Equity
2
1
Long-term debt
0
0
Short-term debt
0
0
Total debt
0
0
Financial ratios
5-year trend
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
2017
2018
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
2017
2018
Return on equity
99.9%
This company
18.4%
Market median
+443% vs market
2017
2018
Net profit margin
140600.0%
This company
8.1%
Market median
+1735702% vs market
2017
2018
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2017
2018
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
2017
2018
Annual reports & filings
Annual report 2018
Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
View
PDF
Annual report 2017
Filed via CVR / Virk · Period 2016-09-12 – 2017-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Former (1)
AR
Axel Rotwitt Bang-Berthelsen
Management
Management
2016 – 2016
Board of directors
Non-executive oversight
Name
Role
Member since
Former (1)
MH
Mads Hartvig Clausen
Board of Directors
2017 – 2020
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
2 BAC Holding IVS
Company
50–66.65%
50–66.65%
2016
Claus Heiner Bang-Berthelsen
Individual
33.33–49.99%
33.33–49.99%
2016
Lasse Westergaard Folkersen
Individual
33.33–49.99%
33.33–49.99%
2016
2200 HOLDING ApS
Company
50–66.65%
50–66.65%
2017
L Folkersen Holding ApS
Company
33.33–49.99%
33.33–49.99%
2016
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Idun Genomics IVS also hold positions in
0
other companies.
Person
Role here
Other companies
Axel Rotwitt Bang-Berthelsen
Management
0 companies
Mads Hartvig Clausen
Board of Directors
0 companies